Grandma’s flu vaccine, and yours

From: POLITICO Future Pulse - Tuesday Nov 01,2022 06:01 pm
The ideas and innovators shaping health care
Nov 01, 2022 View in browser
 
Future Pulse

By Grace Scullion , Ben Leonard and Ruth Reader

CHECKUP

flu shots at a pharmacy

Flu season is here and your doctor wants you to get your shot. | AP

New seasonal flu vaccines aimed at protecting older adults are available for the first time this year.

People 65 and older can get one of three supercharged vaccines: two high-dose vaccines that have up to four times the amount of antigen that triggers the immune response, and one “adjuvanted” vaccine that has the usual amount of antigen plus an adjuvant.

Here's a translation:

What’s an adjuvant?  

In immunology, an adjuvant is a substance added to a vaccine to help improve or stimulate an immune response. The adjuvant used in the flu vaccine is MF59, an oil-in-water emulsion of squalene oil.

What’s squalene?

Squalene is a substance found in human skin, as well as in shark liver oil, among other animals and plants. It’s purified for use in vaccines.

Positive results: An efficacy study of the Fluzone High-Dose Quadrivalent vaccine, one of the high-dose shots, found that it was 24 percent more effective than the standard vaccine in preventing the flu in the older set.

According to the CDC, the adjuvanted and high-dose jabs cause side effects like redness and pain at the injection site, headaches, muscle aches and general discomfort more frequently than standard flu vaccines.

Most flu-related hospitalizations and deaths — up to 70 and 85 percent, respectively — occur in people 65 and older.

History shows: In a good year, the flu vaccine might be 60 percent effective in preventing hospitalization but in a bad year, 30 percent.

Two variables determine how well a vaccine performs: the amount of flu activity in a given season and how the vaccine’s composition matches up with circulating versions of the virus, L.J Tan, chief policy and partnerships officer for Immunize.org, a nonprofit group that promotes vaccination, and co-chair of the National Adult and Influenza Immunization Summit, told Future Pulse.

“Because we’ve had two years of low flu activity, our surveillance is not as good as it normally is,” said Tan. Epidemiologists attribute the low flu activity to the public’s efforts to avoid Covid-19. Scientists had fewer data and more guesswork in concocting this year’s shot.

Last year, vaccinated people were 35 percent less likely to get the flu than unvaccinated people. A 2021 study found that vaccinations led to a 31 percent decrease in the risk of death.

The CDC reports that 137 million vaccines have been distributed as of Oct. 22, which is about the same as last year, when a record 194 million doses were distributed in the U.S. by the end of the flu season.

6 percent

The decline in flu vaccine uptake compared with pre-pandemic levels, according to the CDC.

A map of the United State featuring flu levels by state, with the highest in the Southeast.

The future of seasonal flu: Clinical trials for a new type of flu vaccine developed using the same mRNA technology that produced the Pfizer and Moderna Covid-19 vaccines began this fall.

This new flu-fighting technology appears at a time when epidemiologists remain concerned that a long-feared “twindemic” could be coming, especially since flu vaccine uptake has shown no sign of rebounding after dropping amidst the Covid-19 pandemic.

A universal flu vaccine — a shot that could be taken every few years and protect against nearly all types of the virus — is “still years down the road,” Tan said.

 

DON’T MISS A THING FROM THE MILKEN INSTITUTE’S MIDDLE EAST AND AFRICA SUMMIT: POLITICO is partnering with the Milken Institute to produce a special edition "Digital Future Daily" newsletter with insider reporting and insights from the Milken Institute's Middle East and Africa Summit happening November 17-18. Hundreds of global leaders will convene, highlighting the important role connection plays in advancing global well-being. Whether you’re in-person at the event or following online, sign up for this special edition newsletter for daily coverage of the event. SUBSCRIBE TODAY .

 
 
WELCOME TO FUTURE PULSE

BRIAN HEAD, UT - JULY 16: Aspen trees stand in a forest on July 16, 2014 near Brian Head, Utah. Southern Utah is a popular tourist destination. (Photo by Sean Gallup/Getty Images)

Getty Images

This is where we explore the ideas and innovators shaping health care. 

The Supreme Court heard arguments on Monday in a challenge to race-conscious admissions programs at Harvard and the University of North Carolina. Health care analysts are wondering whether a court decision barring or restricting those practices could also limit efforts to end racial disparities in health care, such as in vaccine allocation and uptake.

Share news, tips and feedback with Ben Leonard at bleonard@politico.com, Ruth Reader at rreader@politico.com, Carmen Paun at cpaun@politico.com or Grace Scullion at gscullion@politico.com. 

Send tips securely through SecureDrop, Signal, Telegram or WhatsApp.

Today on our Pulse Check podcast, Lauren Gardner talks with Alice Miranda Ollstein about how the increase in RSV cases casts attention on a handful of drugmakers with vaccines in the pipeline. Plus, Alice's dispatch from Michigan where Gov. Gretchen Whitmer is trying to make an economic case for abortion rights.

Play audio

Listen to today’s Pulse Check podcast

FOLLOW THE MONEY

FILE - This Aug. 11, 2019 file photo shows Visa credit cards in New Orleans. If you’re trying to navigate inflation costs, some lesser-known money moves can unlock savings on your credit card. Whether you’re looking to ditch an annual fee, earn better rewards or make the most of cardholder incentives, familiarize yourself with actions that can free up money to put toward other goals. (AP Photo/Jenny Kane, File)

The Consumer Financial Protection Bureau says $88 billion in U.S. medical bills is currently in collections – affecting one in five Americans. | AP

Inflation is weighing on Americans’ health care decisions, a new survey from Deloitte found.

  • More than a quarter of consumers (or about 72 million U.S. adults) feel less ready in 2022 to pay for unexpected health care costs than they did in 2021. 
  • Three-quarters of those adults say inflation is adding to their expenses.
  • About a third of consumers surveyed say they’re considering less expensive health insurance plans. 

Those findings mean patients could delay or avoid care. And that could compound risks they took during the Covid-19 pandemic when many patients forewent visits to the doctor.

The reverberations could affect health outcomes — and providers’ bottom lines — for years to come.

“Delays can sometimes be like a high-interest credit card that builds up over time and creates high costs down the road because the disease has progressed significantly,” Asif Dhar, vice chair and U.S. life sciences and health care industry leader at the consultancy, told Future Pulse.

Political repercussions: The rise in health care costs is set to become another big issue for President Joe Biden, and it’s unlikely he’ll see costs in check before his term ends, POLITICO’s Sam Sutton reported.

“Economists, business leaders and health care industry experts are warning that the wage, revenue and supply chain pressures that hammered the margins of hospitals and clinics during the pandemic are about to send health coverage and out-of-pocket medical bills through the roof,” Sam wrote.

 

TUNE IN TO THE PULSE CHECK PODCAST: Keep your finger on the pulse of the biggest stories in health care by listening to our daily Pulse Check podcast. POLITICO’s must-listen briefing decodes healthcare policy and politics, and delivers reality checks from health professionals on the front lines. SUBSCRIBE NOW AND START LISTENING .

 
 
ART OF MEDICINE

Research on telehealth has shown it has the potential to improve the quality of care in a several areas, including treatment for addiction , primary care and chronic disease management .

But a new study published in JAMA Network Open suggests that virtual visits aren’t the best way to follow up with patients after a trip to the emergency room.

When compared with patients who had in-person follow-ups, telehealth patients were:

  • More likely to return to the emergency department 
  • More likely to be hospitalized

The researchers from UCLA and the University of Pennsylvania said the findings demonstrate that there needs to be further research into telehealth as a way of providing follow-up care.
“As policy makers, health systems, and patients consider how to use telehealth to increase access to care, these findings suggest that telehealth may not be the best modality for all types of encounters,” they wrote.

 

Follow us on Twitter

Ben Leonard @_BenLeonard_

Ruth Reader @RuthReader

Carmen Paun @carmenpaun

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Please click here and follow the steps to .

More emails from POLITICO Future Pulse

Oct 31,2022 06:01 pm - Monday

The FDA shows caution with abortion pills

Oct 28,2022 06:01 pm - Friday

The last of the Covid vaccine mandates

Oct 27,2022 06:01 pm - Thursday

How states block Medicaid from innovating

Oct 26,2022 06:01 pm - Wednesday

Your pharmacy: The one-stop-health-shop

Oct 25,2022 06:01 pm - Tuesday

Why telehealth cuts both ways

Oct 21,2022 06:01 pm - Friday

New Covid variants under the microscope